Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

BACKGROUND: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19). OBJECTIVE: To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients. DESIGN: Randomized, double-blind, placebo-controlled trial conducted from 22 March through 20 May 2020...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intern Med
Main Authors: Skipper, Caleb P., Pastick, Katelyn A., Engen, Nicole W., Bangdiwala, Ananta S., Abassi, Mahsa, Lofgren, Sarah M., Williams, Darlisha A., Okafor, Elizabeth C., Pullen, Matthew F., Nicol, Melanie R., Nascene, Alanna A., Hullsiek, Kathy H., Cheng, Matthew P., Luke, Darlette, Lother, Sylvain A., MacKenzie, Lauren J., Drobot, Glen, Kelly, Lauren E., Schwartz, Ilan S., Zarychanski, Ryan, McDonald, Emily G., Lee, Todd C., Rajasingham, Radha, Boulware, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Physicians 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7384270/
https://ncbi.nlm.nih.gov/pubmed/32673060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-4207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados